Knowles (KN) Stock Overview
Offers capacitors, radio frequency (RF) and microwave filters, balanced armature speakers, and medtech microphones in Asia, the United States, Europe, rest of Americas, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
KN passed our risk checks.
KN Community Fair Values
Create NarrativeSee what 6 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Knowles Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$35.55 |
| 52 Week High | US$42.93 |
| 52 Week Low | US$20.57 |
| Beta | 1.6 |
| 1 Month Change | 6.69% |
| 3 Month Change | -16.94% |
| 1 Year Change | 57.37% |
| 3 Year Change | 143.66% |
| 5 Year Change | 86.42% |
| Change since IPO | 23.91% |
Recent News & Updates
Knowles: Better Components, Better Earnings, A Fuller Price
Summary Knowles has transformed into a precision components and med-tech audio supplier, improving its earnings mix and operational performance. KN’s current valuation reflects optimism, with a forward adjusted P/E of 22.4, leaving little margin for error or unexpected setbacks. Factory utilization, improved margins, and sustained demand are visible, but further proof of durable earnings and cash conversion is needed for a bullish stance. I maintain a neutral rating as KN’s price rewards operational progress but offers limited upside without stronger evidence of sustainable outperformance or a lower entry point. Read the full article on Seeking AlphaKN: Medical Device Partnership And Buybacks Will Support Future Upside Potential
Analysts now set a higher price target for Knowles at $48, up from $39, citing updated assumptions for revenue growth, profit margins, and future P/E that are reflected in their refined discount rate. What's in the News for Knowles Elucent Medical selected Knowles to manufacture a smart surgical guidance device used with Elucent's EnVisio In-Body Spatial Intelligence System, produced at an ISO 13485 certified and FDA registered facility in Penang, Malaysia.Recent updates
Shareholder Returns
| KN | US Electronic | US Market | |
|---|---|---|---|
| 7D | -3.7% | -5.0% | -0.2% |
| 1Y | 57.4% | 38.1% | 11.9% |
Return vs Industry: KN exceeded the US Electronic industry which returned 38.1% over the past year.
Return vs Market: KN exceeded the US Market which returned 11.9% over the past year.
Price Volatility
| KN volatility | |
|---|---|
| KN Average Weekly Movement | 7.2% |
| Electronic Industry Average Movement | 9.0% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in US Market | 15.0% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: KN has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: KN's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1946 | 5,200 | Jeff Niew | www.knowles.com |
Knowles Corporation offers capacitors, radio frequency (RF) and microwave filters, balanced armature speakers, and medtech microphones in Asia, the United States, Europe, rest of Americas, and internationally. It operates in two segments, Precision Devices (PD) and Medtech & Specialty Audio (MSA). The PD segment focuses on the custom design and delivery of high performance capacitor products and RF solutions primarily serving the defense, industrial, medtech, and electrification/energy markets.
Knowles Corporation Fundamentals Summary
| KN fundamental statistics | |
|---|---|
| Market cap | US$3.04b |
| Earnings (TTM) | US$73.20m |
| Revenue (TTM) | US$635.00m |
Is KN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KN income statement (TTM) | |
|---|---|
| Revenue | US$635.00m |
| Cost of Revenue | US$347.60m |
| Gross Profit | US$287.40m |
| Other Expenses | US$214.20m |
| Earnings | US$73.20m |
Last Reported Earnings
Jun 30, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.86 |
| Gross Margin | 45.26% |
| Net Profit Margin | 11.53% |
| Debt/Equity Ratio | 16.5% |
How did KN perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/20 00:54 |
| End of Day Share Price | 2026/09/18 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Knowles Corporation is covered by 10 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Tristan Gerra | Baird |
| Alex Gauna | Citizens JMP Securities, LLC |
| Robert Labick | CJS Securities, Inc. |